CHELSEA ASHCROFT: Open Payments
NPI 1386175016 · LOWVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $95 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| Alkermes, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Biogen, Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, COBENFY, INVEGA SUSTENNA, ZURZUVAE, INGREZZA.
Industry payments across NY — which companies pay providers there.
